The explainable second reader for cancer sign-out.
Vayden provides deterministic AJCC/FIGO staging support and flags missing or contradictory elements as you sign out — every recommendation transparent and backed by guideline references. It advises, it never decides.
Cancer sign-out is rule-heavy and unforgiving.
AJCC staging changes by edition, CAP-required elements are easy to omit under pressure, and internal contradictions slip through. A single missed positive node can under-stage a patient. The mechanical, rule-bound parts of sign-out deserve a tireless second reader — one that keeps the judgment where it belongs: with the pathologist.
Staging support, clearly explained.
Vayden provides consistent AJCC 8th / FIGO staging and report-completeness support, and flags missing required elements or internal contradictions — surfacing relevant biomarker, hereditary, and prognostic-risk context along the way. Every recommendation is transparent and backed by guideline references, and Vayden never alters, blocks, or writes your report.
Three promises — and they compound.
Deterministic, not a black box
Consistent, reproducible recommendations you can rely on — and every one is transparent and easy to review, never a black box.
It advises, it never decides
Vayden never changes, blocks, or writes your report. It’s a second reader, not a decision-maker. Your judgment governs, always.
Transparent and reviewable
Every recommendation includes supporting guideline references and a clear confidence level — so you can review it in seconds against a source you already trust.
Privacy is built in: your data stays within your institution.
On-premise, inside your firewall. Designed so that no PHI reaches the vendor. No internet access required — air-gap supported. Behind your SSO, in a hardened, isolated environment, with a full audit trail.
- On-premise — runs inside your firewall
- No PHI to the vendor — de-identified analysis only
- No outbound network — air-gap supported
- Institutional SSO + full, exportable audit trail
- SBOM provided — supply-chain transparency
- Read-only during the pilot — writes nothing back to your LIS/EHR
Where we are — the honest part
Vayden is investigational and not FDA-cleared. It has been validated internally, but not yet against external, independently adjudicated real-world cases. Producing that evidence is exactly what our first pilot does. We’d rather tell you that plainly than overclaim.
One academic department. One rigorous, publishable study.
We’re seeking one academic pathology department for a structured, non-interventional pilot — setup, then silent/shadow evaluation, then optional assistive use — all under IRB oversight, on de-identified data. You get a rigorous, publishable external concordance study and a hand in the roadmap. It comes turn-key: protocol, installation, training, validation materials, feedback instruments, metrics dashboard, and IRB/consent materials.
What you get
- A publishable concordance study
- Reproducible completeness & consistency checking
- Roadmap influence & early-partner terms
- $0 license — a research collaboration
The questions we get first.
Is it a black box?
No. Vayden’s recommendations are deterministic and transparent — every one includes its supporting guideline references, so you can always review it.
Does it make diagnoses?
No. It offers staging and completeness support with supporting guideline references; the diagnosis and the report are entirely yours.
Does our data leave the building?
By design, no. On-premise, no PHI reaches the vendor, and it needs no outbound connection. Analysis runs on de-identified data.
Is it FDA-cleared?
Not yet — it’s investigational. A first pilot runs non-interventionally under IRB, so no clearance is required for that use.
An independent team, one problem.
Vayden is built by an independent medical-software team focused on a single problem: making cancer sign-out more consistent and transparent, without taking the diagnosis out of the pathologist’s hands. We believe pathologists deserve decision support they can trust and review — and that the final judgment must always remain theirs.
Assistant Professor of Pathology, Grant Government Medical College & Sir J.J. Group of Hospitals, Mumbai
Dr. Vishal Tayade is an Assistant Professor of Pathology at Grant Government Medical College & Sir J.J. Group of Hospitals, Mumbai. He trained at Tata Memorial Centre, completed MD Pathology, and passed FRCPath Part 1 (Histopathology). He founded Vayden to build deterministic, explainable clinical decision support that assists pathologists without replacing their judgment.
Institutional affiliation is shown for identification only and does not imply endorsement of Vayden by these institutions.
LinkedInIf your department stages cancer, let’s talk.
Thirty minutes, a ten-minute demo, and an honest conversation about whether a first validation pilot is a fit.
Request a pilot conversationOr email us directly: pilot@vayden.in